Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Feb;23(2):111-116.
doi: 10.1002/humu.10299.

Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene

Lan Kluwe  1 , Reiner Siebert  2 , Stefan Gesk  2 , Reinhard E Friedrich  1 , Sigrid Tinschert  3 , Hildegard Kehrer-Sawatzki  4 , Victor-F Mautner  5
Affiliations

Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene

Lan Kluwe et al. Hum Mutat. 2004 Feb.

Abstract

A total of 500 unselected unrelated neurofibromatosis 1 (NF1) patients were screened for deletions of the NF1 gene. After excluding 67 patients with known intragenic NF1 mutations, the remaining 433 were genotyped using six intragenic and one distal microsatellite marker for the NF1 gene. A total of 28 patients were hemi- or homozygous for all seven markers and were thus considered as candidates for NF1 deletion with a calculated probability of 99.99%. Metaphase or interphase cells were available from 23 of these 28 individuals for molecular cytogenetics. Fluorescence in situ hybridization (FISH) confirmed an NF1 deletion in 22 (96%) of the 23 patients. Thus, a constitutional deletion of the NF1 gene is responsible for the disease phenotype in at least 4.4% of the 500 unselected NF1 patients. Genotyping using multiple microsatellite markers may provide a simple, inexpensive, and efficient strategy for screening deletions of the NF1 gene, and can as well be applied for other large genes.

PubMed Disclaimer

References

REFERENCES

    1. Armour JAL, Barton DE, Cockburn DJ, Taylor GR. 2002. The detection of large deletions or duplications in genomic DNA. Hum Genet 20:325-337.
    1. Ars E, Serra E, García J, Kruyer H, Gaona A, Lázaro C, Estivill X. 2000. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. Hum Mol Genet 9:237-247.
    1. Bougeard G, Brugieres L, Chompret A, Gesta P, Charbonnier F, Valent A, Martin C, Raux G, Feunteun J, Bressac-de Paillerets B, Frebourg T. 2003. Screening for TP53 rearrangements in families with the Li-Fraumeni syndrome reveals a complete deletion of the TP53 gene. Oncogene 22:840-846.
    1. Casilli F, DiRocco ZC, Gad S, Tournier I, Stoppa-Lyonnet D, Frebourg T, Tosi M. 2002. Rapid detection of novel BRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluoresecent fragments. Hum Mutat 20:218-226.
    1. Cawthon R, Weiss R, Xu G, Viskochil D, Vulver M, Stevens J, Robertson M, Dunn D, Gesteland R, O'Connell P, White R. 1990. A major segment of neurofibromatosis type 1 gene: cDNA sequence, genomic structure and point mutations. Cell 62:193-201.

Publication types

Substances

Associated data

LinkOut - more resources